南京兰铭医疗科技

Nanjing Lanming Medical Technology is a Chinese medical device company specializing in the development and manufacturing of high-end vascular interventional products. The company's core expertise lies in its proprietary drug-coated balloon (DCB) technology platform, which is designed for the treatment of various vascular stenotic diseases. Its flagship product, a paclitaxel-eluting PTCA balloon catheter, has received regulatory approval in China for coronary interventions. Lanming Medical is actively expanding its portfolio to include solutions for peripheral arterial disease and arteriovenous fistula maintenance. Based in Nanjing, the company integrates research, clinical development, and GMP-compliant manufacturing to serve the growing interventional medicine market. Through its focus on precision drug delivery, Lanming Medical aims to improve long-term clinical outcomes for patients with cardiovascular conditions.